Francesco Pietro Crispino
Director/Board Member en APOLLO TYRES LIMITED .
Perfil
Francesco Pietro Crispino is the founder of Greater Pacific Capital LLP.
He is currently an Independent Director at Apollo Tyres Ltd.
He was previously a Director at Stallergenes Greer Ltd.
from 2019 to 2021 and held the position of Chief Strategy Officer & Executive VP at BCE, Inc. Mr. Crispino has a graduate degree from the University of Oxford and the University of Chicago, and an undergraduate degree from the University of Toronto.
Cargos activos de Francesco Pietro Crispino
Empresas | Cargo | Inicio |
---|---|---|
APOLLO TYRES LIMITED | Director/Board Member | 03/07/2020 |
Antiguos cargos conocidos de Francesco Pietro Crispino.
Empresas | Cargo | Fin |
---|---|---|
STALLERGENES GREER | Director/Board Member | 31/12/2021 |
Greater Pacific Capital LLP
Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Founder | - |
BCE INC. | Corporate Officer/Principal | - |
Formación de Francesco Pietro Crispino.
University of Oxford | Graduate Degree |
The University of Chicago | Graduate Degree |
University of Toronto | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BCE INC. | Communications |
APOLLO TYRES LIMITED | Consumer Durables |
Empresas privadas | 2 |
---|---|
Greater Pacific Capital LLP
Greater Pacific Capital LLP Investment ManagersFinance Greater Pacific Capital LLP (Greater Pacific Capital) is a private equity firm founded in 2005 by Ketan J Patel and Methusalah Joseph Sealy. The firm is headquartered in London. | Finance |
Stallergenes Greer Ltd.
Stallergenes Greer Ltd. Pharmaceuticals: MajorHealth Technology Stallergenes Greer Ltd. is a healthcare company, which engages in the development and commercialization of allergy immunotherapy products and services. Its products include sublingual products, subcutaneous products, and veterinary products. The company was founded on December 6, 2013 and headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Francesco Pietro Crispino